Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (26) , 24443-24450
- https://doi.org/10.1074/jbc.m502825200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Generation of a floxed allele of the mouse BMP type II receptor geneGenesis, 2005
- BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cellsOncogene, 2004
- Phosphorylation Regulates Id3 Function in Vascular Smooth Muscle CellsCirculation Research, 2004
- Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cellsOncogene, 2004
- Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertensionHuman Molecular Genetics, 2003
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1The Journal of cell biology, 2003
- Smooth Muscle α-Actin Gene Requires Two E-Boxes for Proper Expression In Vivo and Is a Target of Class I Basic Helix-Loop-Helix ProteinsCirculation Research, 2003
- Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial CellsCirculation, 2002
- Molecular cloning and binding properties of the human type II activin receptorBiochemical and Biophysical Research Communications, 1992